4-Bromo-3-fluoro-2-methoxy-benzaldehyde, 95%, 50mg

(3R,4S)-rel-4-amino-1-methylpyrrolidin-3-ol dihydrochloride, 97.0%, 500mg

6-BROMO-2H-BENZO[B][1,4]THIAZIN-3(4H)-ONE, 97.0%, 1g

(1-(Phenylsulfonyl)-1H-indol-6-yl)boronic acid, 95%, 1g

Methyl 4-(chlorosulfonyl)-1-methyl-1h-pyrrole-2-carboxylate, 97%, 250mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)decanoic acid, 97%, 250mg

6-BROMO-8-FLUORO-2-METHYLIMIDAZO[1,2-A]PYRIDINE, 95.0%, 10g

3-METHYL-4-(4-METHYLPIPERAZIN-1-YL)ANILINE, 95%, 250mg

(Z)-1,2-Bis(phenylsulfonyl)ethene, 95.0%, 5g

(2R,4R)-Ethyl 1-(2-amino-5-(3-nitroguanidino)pentanoyl)-4-methylpiperidine-2-carboxylate hydrochloride, 95%, 10g

2-(2-Aminoethoxy)-1,1-dimethoxyethane, 98.0%, 100g

Methyl 2-(4-(tert-butyl)phenyl)acetate, 95.0%, 25g

Escualeno, mínimo 90 %, para síntesis, 500 ml, envase de vidrio